The USA’s Food & Drug Administration (FDA) have revealed a likely shift in blood donation rules.
Since the 1980s these have discriminated against bi and gay men, and other men who have sex with men. The rules came in initially in response to HIV/AIDS.
At that time a blanket ban was the best instrument available given testing was limited and understanding of the virus was so basic.
In the ensuing decades research and development of drugs like PrEP and medication regimes for people who have HIV have entirely changed that situation. In countries like the UK and Canada, there has been a slow move from a blanket ban, to a ban on donating blood within a certain amount of time since your last sex with a gay or bi man.
In the US the blanket ban was lifted in 2015 becoming a 12 month delay, copying a move in the UK three years earlier.
The FDA is now proposing to follow other countries by replacing a shorter “3 month ban” introduced at the start of the COVID pandemic with individual risk assessments based on revent sexual behaviour.
American campaign group GLAAD responded to the news, with CEO Sarah Kate Ellis commenting, “While today’s reports of an overdue move from the FDA is an important step, our community and leading medical experts will not stop advocating for the FDA to lift all restrictions against qualified LGBTQ blood donor candidates. As LGBTQ leaders and medical experts have been saying for years: bans and restrictions on blood donations from gay and bisexual men are rooted in stigma, not science. Giving one set of rules to some people, and another set of rules to others, based purely on identity, is blatant discrimination. This fight is not over until all LGBTQ Americans who want to donate blood are met with the same protocols as other Americans.
“All potential blood donors, whose donations could save lives, should be treated equally. There is no excuse for choosing stigma over science in 2022.”
